Siste oppdatering :
19/11/2024
Infostab
Lister
Sammendrag
Søk etter kompatibilitet
Y-side kompatibilitetstabell
Referanser
Forskerteamet
valistab
plakat
Tilkoblinger
sponsorer
Forfatter
Instruksjon
Nyhetsbrev
Referanser 4723
Type :
Journal
Internett-koblingen :
;80,1:53-58
Forskerteamet :
Tokyo - Nippon Medical School Hospital, Department of Pharmacy
Forfattere :
Kondo M, Yoshida N, Yoshida M, Tanaka C, Tagami T, Horik K, Sugaya K, Takase H
Tittel :
Physical compatibility of remimazolam with opioid analgesics, sedatives, and muscle relaxants during simulated Y-site administration.
Nummer :
Am J Health-Syst Pharm https://doi.org/10.1093/a 2022
Nivå of Evidence :
fysisk stabilitet :
kjemisk stabilitet :
andre metoder :
Kommentarer :
Lister
Dexmedetomidine
4 µg/ml
+
Remimazolam
5 mg/ml
+
Fentanyl citrate
50 µg/ml
+
Remimazolam
5 mg/ml
+
Midazolam hydrochloride
5 mg/ml
+
Remimazolam
5 mg/ml
+
Remifentanil hydrochloride
100 µg/ml
+
Remimazolam
5 mg/ml
+
Remimazolam
5 mg/ml
+
Dexmedetomidine
4 µg/ml
+
5 mg/ml
+
Fentanyl citrate
50 µg/ml
+
5 mg/ml
+
Midazolam hydrochloride
5 mg/ml
+
5 mg/ml
+
Remifentanil hydrochloride
100 µg/ml
+
5 mg/ml
+
Rocuronium bromide
10 mg/ml
+
5 mg/ml
+
Vecuronium bromide
1 mg/ml
+
Rocuronium bromide
10 mg/ml
+
Remimazolam
5 mg/ml
+
Vecuronium bromide
1 mg/ml
+
Remimazolam
5 mg/ml
+
Mentions Légales
